Search

Your search keyword '"Martiniuc A"' showing total 246 results

Search Constraints

Start Over You searched for: Author "Martiniuc A" Remove constraint Author: "Martiniuc A" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
246 results on '"Martiniuc A"'

Search Results

1. Management of a case of colovesical fistula with fecaluria as first sign

2. CDKN2A exon 1B deletion predisposing to melanoma and neural system tumour syndrome.

3. SIGURANȚA PACIENTULUI: PROVOCĂRI MODERNE ȘI MĂSURI DE ASIGURARE ÎN DOMENIUL MEDICAL

4. BUB1B mutation in a woman with cutaneous melanoma and multiple other primary malignancies

5. Production of Recombinant Biopharmaceuticals in Chlamydomonas reinhardtii

6. A new CECR1 mutation associated with severe hematological involvement in ADA2 deficiency

8. The clinical consequences of SARS-CoV-2 infection in patients with pancreaticoduodenectomy for malignant disease

10. Paired spiking robustly shapes spontaneous activity in neural networks in vitro

11. Surgical Treatments for Women with Stress Urinary Incontinence: A Systematic Review

13. Kinetics of early and late molecular recurrences after first-line imatinib cessation in chronic myeloid leukemia: updated results from the STIM2 trial

14. Opportunities of Fenspiride anti-inflammatory therapy in patients with chronic obstructive pulmonary disease

18. Efficacy of Valsartan vs. Perindopril in pulmonary hypertension and endothelial function control in patients with chronic obstructive pulmonary disease

19. A new CECR1 mutation associated with severe hematological involvement in ADA2 deficiency

23. A CASE REPORT AND ANATOMICAL CONSIDERATIONS ON TRACHEOESOPHAGEAL FISTULA OF UNCERTAIN ETIOLOGY.

24. Trends on Chlamydomonas reinhardtii growth regimes and bioproducts.

25. Data from Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients

27. Supplementary Data from Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients

28. Data from Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients

29. Sensing Precursors of Illegal Drugs—Rapid Detection of Acetic Anhydride Vapors at Trace Levels Using Photoionization Detection and Ion Mobility Spectrometry

30. Modulation of cell signalling and sulfation in cardiovascular development and disease

31. Production of recombinant biopharmaceuticals in Chlamydomonas reinhardtii

32. Pancreatoduodenectomy for Malignant Solid Pseudopapillary Neoplasm in a Patient with Chronic Calcifying Pancreatitis, Rheumatoid Polyarthritis and Kidney Stones

33. The evaluation of the on-board computer architecture for TUMnanoSAT series of nanosatellites for carrying out missions

34. The method of measuring the parameters of nanostructured sensors

35. A new CECR1 mutation associated with severe hematological involvement in ADA2 deficiency

39. Loss of NDR1/2 kinases impairs endomembrane trafficking and autophagy leading to neurodegeneration

46. Pancreatic Fistula after D1+/D2 Radical Gastrectomy according to the Updated International Study Group of Pancreatic Surgery Criteria: Risk Factors and Clinical Consequences. Experience of Surgeons with High Caseloads in a Single Surgical Center in Eastern Europe

47. CDKN2A exon 1B deletion predisposing to melanoma and neural system tumour syndrome

48. SARS-CoV-2 infection in liver transplant recipients-a single center case series from Romania

50. Kinetics of early and late molecular recurrences after first-line imatinib cessation in chronic myeloid leukemia: updated results from the STIM2 trial

Catalog

Books, media, physical & digital resources